Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Learn more at www.Regeneron.com.

With our focus on science and innovation we’re not afraid to pave the way in unserved rare diseases, like FOP. Working together with the FOP community we vow to listen and learn to inform our medicines development. As unique challenges require unique solutions to benefit patients and society. Ipsen: Focus, Together, For Patients and Society.